Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis

NCT05451615 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Abatacept
Treatment Compliance
Rheumatoid Arthritis

Interventions

DRUG: Janus Kinase Inhibitor
DRUG: Abatacept

Sponsor

Zhejiang Provincial People's Hospital